These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17451980)

  • 1. Placebo response in the prophylaxis of migraine: a meta-analysis.
    Macedo A; Baños JE; Farré M
    Eur J Pain; 2008 Jan; 12(1):68-75. PubMed ID: 17451980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls.
    Loder E; Goldstein R; Biondi D
    Cephalalgia; 2005 Feb; 25(2):124-31. PubMed ID: 15658949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The placebo response in studies of acute migraine.
    Fernandes R; Ferreira JJ; Sampaio C
    J Pediatr; 2008 Apr; 152(4):527-33, 533.e1. PubMed ID: 18346509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
    Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
    Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials.
    Macedo A; Farré M; Baños JE
    Eur J Clin Pharmacol; 2006 Mar; 62(3):161-72. PubMed ID: 16402240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis.
    Goadsby PJ; Ferrari MD; Csanyi A; Olesen J; Mills JG;
    Cephalalgia; 2009 Jul; 29(7):742-50. PubMed ID: 19222510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo efficacy in childhood and adolescence migraine: an analysis of double-blind and placebo-controlled studies.
    Evers S; Marziniak M; Frese A; Gralow I
    Cephalalgia; 2009 Apr; 29(4):436-44. PubMed ID: 19170687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
    Schellenberg R; Lichtenthal A; Wöhling H; Graf C; Brixius K
    Headache; 2008 Jan; 48(1):118-25. PubMed ID: 18184294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acupuncture in migraine prevention: a randomized sham controlled study with 6-months posttreatment follow-up.
    Alecrim-Andrade J; Maciel-Júnior JA; Carnè X; Severino Vasconcelos GM; Correa-Filho HR
    Clin J Pain; 2008 Feb; 24(2):98-105. PubMed ID: 18209514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
    Freitag F; Smith T; Mathew N; Rupnow M; Greenberg S; Mao L; Finlayson G; Wright P; Biondi D;
    Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.
    Aurora SK; Rozen TD; Kori SH; Shrewsbury SB
    Headache; 2009 Jun; 49(6):826-37. PubMed ID: 19545249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of the efficacy of a single dose of phenylephrine 10 mg compared with placebo in adults with acute nasal congestion due to the common cold.
    Kollar C; Schneider H; Waksman J; Krusinska E
    Clin Ther; 2007 Jun; 29(6):1057-70. PubMed ID: 17692721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine.
    Saper JR; Mathew NT; Loder EW; DeGryse R; VanDenburgh AM;
    Pain Med; 2007 Sep; 8(6):478-85. PubMed ID: 17716321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies.
    Leentjens AF; Koester J; Fruh B; Shephard DT; Barone P; Houben JJ
    Clin Ther; 2009 Jan; 31(1):89-98. PubMed ID: 19243709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose intravenous tramadol for acute migraine pain in adults: a single-blind, prospective, randomized, placebo-controlled clinical trial.
    Alemdar M; Pekdemir M; Selekler HM
    Clin Ther; 2007 Jul; 29(7):1441-7. PubMed ID: 17825695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database.
    Dodick DW; Lipton RB; Goadsby PJ; Tfelt-Hansen P; Ferrari MD; Diener HC; Almas M; Albert KS; Parsons B
    Headache; 2008 Feb; 48(2):184-93. PubMed ID: 18234045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.